FAST NEWS: MicroPort MedBot vascular surgical robot approved in China
The latest: Shanghai MicroPort MedBot (Group) Co. Ltd. (2522.HK) announced on Wednesday its R-ONE Vascular Interventional Surgical Robot jointly developed with France’s Robocath S.A.S has been approved by China’s National Medical…
2252.HK
Recent Articles
RELATED ARTICLES
-
BRIEF: MicroPort MedBot raises $35 million in share placement at 20% discount
2252.HK
-
Everest gets boost from core product Nefecon’s inclusion in China’s national health plan
1952.HK
-
Jinko sees sunnier skies in Germany with new fundraising plan
JKS.US 688223.SHG
- BRIEF: Yimutian approved by China for Nasdaq IPO
-
China Oriental Group eyes green escape from overheated steel furnace
0581.HK
- Shanghai family feud ties up $1 billion in property, offers lesson for investors
Discover hidden China stock gems in our weekly newsletter